Keyphrases
United Kingdom
100%
COVID-19
93%
Venom Immunotherapy
57%
Hereditary Angioedema
55%
Cost-effectiveness
42%
Clinical Immunology
39%
Allergy Immunology
39%
Differential Diagnosis
37%
Anaphylaxis
37%
Abnormal Uterine Bleeding
37%
Platform Trials
37%
AIDS/HIV
37%
Polypectomy
37%
Vesicoamniotic Shunting
37%
Randomized Controlled Trial
37%
Interferon-gamma Release Assay
32%
Lower Urinary Tract Obstruction
31%
Long-term Prophylaxis
31%
Tuberculin Skin Test
29%
Serum IgE
28%
National Survey
27%
Uterine Polyp
27%
Allergy
25%
Prescription Rate
24%
Skin Test
24%
Poor Outcome
24%
Hymenoptera Venom Allergy
23%
Tuberculosis
22%
COVID-19 Treatment
22%
British Society
21%
Polyps
20%
Allergic Diseases
20%
Pediatric Food Allergy
20%
Allergy Clinic
20%
Congenital Lower Urinary Tract Obstruction
19%
Interferon-γ
19%
Economic Evaluation
18%
Aspirin
18%
Academy
18%
Randomized Evaluation
18%
Tuberculosis Diagnosis
18%
Emergency Care
18%
Patient Experience
18%
Network Database
18%
Venom
18%
In Vitro Activation
18%
Autoinjector
18%
Rituximab
18%
Shunt
18%
Vesicoamniotic Shunt
18%
Medicine and Dentistry
COVID-19
74%
Cost-Effectiveness Analysis
41%
Randomized Controlled Trial
40%
Outpatient
37%
Shunting
37%
Polyp
37%
Uterus Bleeding
37%
Urinary Tract Obstruction
37%
Hereditary Angioedema
37%
Polypectomy
33%
Immunotherapy
26%
Pediatrics
23%
Infection
20%
Epinephrine
20%
Immunoglobulin E
18%
Retrospective Cohort Study
18%
General Medicine
18%
Bordetella Pertussis
18%
Systematic Review
18%
Azithromycin
18%
Autoinjector
18%
T Cell
18%
Food Allergy
18%
Mycobacterium Tuberculosis
18%
Patient Experience
18%
Adenylate Cyclase
18%
Spleen Rupture
18%
Emergency Care
18%
Dipeptidyl Peptidase
18%
Human Immunodeficiency Virus
18%
Ex Vivo
18%
Placebo
18%
Cohort Study
18%
COVID-19 Therapy
18%
Primary Health Care
18%
Acetylsalicylic Acid
18%
Diseases
18%
Intention-to-Treat Analysis
17%
Health Care Cost
16%
Prospective Study
13%
Arm
13%
Public Health
11%
Odds Ratio
11%
Quality of Life
10%
Artificial Respiration
10%
Nasopharyngeal Swab
9%
Observational Study
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Logistic Regression Analysis
9%
Reverse Transcription Polymerase Chain Reaction
9%